Textul licitației

cations in the production of Actinium-225 (Ac-225) for the use of targeted alpha therapy. Following a surge of demand for Ac-225, Ra-226 material serves as a crucial source material for producing it as well as other valuable medical radioisotopes, such as Lead-212 (Pb-212). With a growing demand and limited supply for Ra-226, the JRC Karlsruhe wants to contribute to the medical isotope supply chain. The expertise along with the state-of-the-art assets at JRC Karlsruhe, equips it to contribute effectively to this critical field. This sale is meant to bolster the availability of Ra-226 for medical applications and further the advancement of nuclear medicine.Identificatorul procedurii: a2c8b963-668e-4f26-8454-11db7332e942Identificator intern: EC-JRC/KRU/2026/CPN/0562Tip de procedură: Negociată cu publicarea prealabilă a unei proceduri concurențiale